• Steroid Lysis of Protoplasts: Methods and Findings

  2026-08-17

  The 1965 study by Smith and Shay used lysozyme-generated Sarcina lutea protoplasts to distinguish steroid-associated membrane damage from effects involving the bacterial cell wall. Its protection experiments with polyamines, metal ions, uranyl nitrate, and surfactants provide a useful framework for interpreting membrane-lysis assays while highlighting the limits of inferring mechanism from optical readouts alone.

• Cy3-UTP for RNA Nanoparticle Assays

  2026-08-16

  Cy3-UTP enables direct visualization of labeled RNA during transcription, nanoparticle formulation, cellular uptake, and RNA detection workflows. Combined with stability and structure assays, it helps distinguish RNA delivery, particle association, and intracellular release rather than treating fluorescence as a standalone transfection readout.

• ERK5 in Vitamin D–Induced Myeloid Differentiation

  2026-08-15

  Wang et al. show that ERK5 and ERK1/2 make distinct contributions to 1α,25-(OH)2 vitamin D3-induced differentiation of HL60 and U937 myeloid leukemia cells. ERK5 inhibition altered CD11b and CD14 expression while producing cell-cycle arrest, revealing pathway-specific control that is not captured by treating MAPK signaling as a single linear module.

• Realgar, Ornithine, and Astrocyte Glycolysis

  2026-08-14

  This 2025 Advanced Science study identifies a liver–brain mechanism linking realgar-derived arsenic, hepatic OTC inhibition, ornithine accumulation, and ZBTB7A-mediated suppression of astrocyte glycolysis. Its multi-model design connects altered urea-cycle metabolism with frontal-lobe energy failure and behavioral impairment, providing a framework for studying arsenic-associated CNS toxicity.

• Engage & Evasion for EV MPS Escape

  2026-08-14

  The 2024 Journal of Nanobiotechnology study introduces a sequential extracellular vesicle strategy that first engages the mononuclear phagocyte system with CD47-low vesicles and then protects CD47-high therapeutic vesicles from uptake. This design reduced liver and spleen entrapment, increased circulating vesicle levels, and improved distribution to non-MPS organs, offering a useful framework for ischemic disease delivery.

• AMD-070 hydrochloride: CXCR4 Workflow Guide

  2026-08-13

  Build reproducible CXCR4 trafficking, signaling, and migration assays with AMD-070 hydrochloride, using practical concentration, timing, and control strategies. The workflow connects bench readouts to the phase 3 WHIM syndrome evidence while clearly separating translational findings from exploratory anti-HIV research.

• L-NAME Hydrochloride: Mechanism and Vascular Research

  2026-08-13

  L-NAME Hydrochloride, also called NG-nitro-L-arginine methyl ester, is a competitive nitric oxide synthase inhibitor used to reduce nitric oxide formation in vascular and cell-based experiments. Its reported activity, formulation properties, and dose ranges support controlled studies of vascular tone regulation, hypertension, and selected inflammation-related endpoints.

• Troglitazone and the PPARγ–TAM Translation Gap

  2026-08-12

  Troglitazone offers a mechanistically interesting bridge between PPAR-driven metabolic biology and tumor-associated macrophage research. This article positions it as a hypothesis-generating PPARγ agonist for testing SPP1-linked myeloid states, while separating product attributes, anchor-study evidence, and translational limitations.

• Arachidonic Acid Accelerates Vaccine Humoral Immunity

  2026-08-12

  The reference study identifies dietary arachidonic acid as a potential immunological adjuvant that accelerates rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the connection between arachidonic acid enrichment in lymph nodes, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• NIAGEN in iPSC-RGC Assay Design

  2026-08-11

  Nicotinamide Riboside Chloride (NIAGEN) can help researchers test how NAD+ availability influences energy homeostasis in stem cell-derived retinal ganglion cell models. This article focuses on assay architecture, reproducibility, and the boundaries between differentiation biology and neuroprotection.

• Verapamil HCl: Calcium Flux, Efflux, Cell Fate

  2026-08-11

  Verapamil HCl is an L-type calcium channel blocker whose experimental effects may reflect both calcium signaling and drug-efflux control. This guide explains how to distinguish those mechanisms in myeloma, apoptosis, and collagen-induced arthritis studies.

• Baicalein Workflows for Apoptosis Research

  2026-08-10

  Baicalein provides a practical chemical perturbation tool for connecting 12-LOX activity with apoptosis, inflammatory signaling, and cancer-cell phenotypes. This workflow emphasizes solvent control, orthogonal readouts, and a paired neuronal–tumor assay strategy inspired by recent chemotherapy-neurotoxicity research.

• In Vitro Drug Response: Viability, Growth, and Death

  2026-08-09

  Hannah R. Schwartz’s dissertation distinguishes drug-induced growth inhibition from actual cell killing, showing that relative viability and fractional viability capture different dimensions of an in vitro cancer response. This framework can improve interpretation of drug screens, particularly when cell-cycle arrest and delayed death occur together.

• MVC Entry via RhoA/ROCK1 Tight-Junction Signaling

  2026-08-08

  Ren and colleagues show that Minute Virus of Canines (MVC) uses a host RhoA/ROCK1/MLC2 signaling axis to remodel tight junctions and expose occludin for VP2-mediated infection. The study connects a direct VP2–ROCK1 interaction with cytoskeletal contraction, barrier permeability, and reduced infection after pharmacologic pathway inhibition.

• Mavorixafor Hydrochloride: Assay Logic

  2026-08-07

  AMD-070 hydrochloride is a CXCR4 antagonist for dissecting chemokine-directed migration and immune-cell phenotypes. This article uses a tissue-perfusion study to show how endpoint selection, controls, and cross-domain limits can improve translational assay design.

558 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page